Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Boulware

Showing results (161-170 of 970) with videos related to

Pageof 97
Sort By:
Lancet Regional Health. Americas|May 9, 2022
Hydroxychloroquine for COVID19: The curtains close on a comedy of errorsIlan S Schwartz, David R Boulware, Todd C Lee
AIDS (London, England)|November 23, 2006
A case for treating high hepatitis B DNA levels before starting HIV therapyJason V Baker, David R Boulware, Paul R Bohjanen
JAMA|February 3, 2016
Academic Health Systems' Third Curve: Population Health ImprovementA Eugene Washington, Molly J Coye, L Ebony Boulware
Primary Care|October 28, 2019
Measuring HealthTheresa M Coles, Lesley H Curtis, L Ebony Boulware
JAMA|December 2, 2020
Removal of Race From Estimates of Kidney Function: First, Do No HarmKeith C Norris, Nwamaka D Eneanya, L Ebony Boulware
Anticancer Research|July 9, 2011
Correlation between COX-2 and APC expression in left versus right-sided human colon cancerA Nasir, A Lopez, D Boulware, et al.
The Lancet. Infectious Diseases|September 28, 2016
Sertraline for HIV-associated cryptococcal meningitis - Authors' replyJoshua Rhein, Kirsten Nielsen, David R Boulware, et al.
Journal of Virus Eradication|February 9, 2016
Towards a scalable HIV cure research agenda: the role of co-infectionsIrini Sereti, Gregory K Folkers, Graeme Meintjes, et al.
Seminars in Nephrology|August 1, 2016
The Economic Burden of Chronic Kidney Disease and End-Stage Renal DiseaseVirginia Wang, Helene Vilme, Matthew L Maciejewski, et al.
Open Forum Infectious Diseases|January 27, 2018
Cryptococcal Disease in the Era of "Test and Treat": Is There Cause for Concern?Mahsa Abassi, Joshua Rhein, David B Meya, et al.
Pageof 97

Showing results (161-170 of 970) with videos related to

Sort By:
Pageof 97
Lancet Regional Health. Americas|May 9, 2022
Hydroxychloroquine for COVID19: The curtains close on a comedy of errorsIlan S Schwartz, David R Boulware, Todd C Lee
AIDS (London, England)|November 23, 2006
A case for treating high hepatitis B DNA levels before starting HIV therapyJason V Baker, David R Boulware, Paul R Bohjanen
JAMA|February 3, 2016
Academic Health Systems' Third Curve: Population Health ImprovementA Eugene Washington, Molly J Coye, L Ebony Boulware
Primary Care|October 28, 2019
Measuring HealthTheresa M Coles, Lesley H Curtis, L Ebony Boulware
JAMA|December 2, 2020
Removal of Race From Estimates of Kidney Function: First, Do No HarmKeith C Norris, Nwamaka D Eneanya, L Ebony Boulware
Anticancer Research|July 9, 2011
Correlation between COX-2 and APC expression in left versus right-sided human colon cancerA Nasir, A Lopez, D Boulware, et al.
The Lancet. Infectious Diseases|September 28, 2016
Sertraline for HIV-associated cryptococcal meningitis - Authors' replyJoshua Rhein, Kirsten Nielsen, David R Boulware, et al.
Journal of Virus Eradication|February 9, 2016
Towards a scalable HIV cure research agenda: the role of co-infectionsIrini Sereti, Gregory K Folkers, Graeme Meintjes, et al.
Seminars in Nephrology|August 1, 2016
The Economic Burden of Chronic Kidney Disease and End-Stage Renal DiseaseVirginia Wang, Helene Vilme, Matthew L Maciejewski, et al.
Open Forum Infectious Diseases|January 27, 2018
Cryptococcal Disease in the Era of "Test and Treat": Is There Cause for Concern?Mahsa Abassi, Joshua Rhein, David B Meya, et al.
Pageof 97